Richard T Christoph Net Worth

The estimated Net Worth of Richard T Christoph is at least $1.12 Миллион dollars as of 22 February 2005. Richard Christoph owns over 40,919 units of Psychemedics stock worth over $76,895 and over the last 21 years Richard sold PMD stock worth over $1,039,447.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Richard Christoph PMD stock SEC Form 4 insiders trading

Richard has made over 2 trades of the Psychemedics stock since 2004, according to the Form 4 filled with the SEC. Most recently Richard sold 40,919 units of PMD stock worth $531,947 on 22 February 2005.

The largest trade Richard's ever made was selling 50,000 units of Psychemedics stock on 7 January 2004 worth over $507,500. On average, Richard trades about 45,460 units every 206 days since 2004. As of 22 February 2005 Richard still owns at least 33,800 units of Psychemedics stock.

You can see the complete history of Richard Christoph stock trades at the bottom of the page.

What's Richard Christoph's mailing address?

Richard's mailing address filed with the SEC is 4601 GULF SHORE BLVD N., UNIT 6, NAPLES, FL, 34103.

Insiders trading at Psychemedics

Over the last 21 years, insiders at Psychemedics have traded over $2,633,903 worth of Psychemedics stock and bought 95,845 units worth $742,060 . The most active insiders traders include Peter Kamin, A Clinton Allen и Raymond C Jr Kubacki. On average, Psychemedics executives and independent directors trade stock every 101 days with the average trade being worth of $18,935. The most recent stock trade was executed by Charles M Doucot on 17 August 2023, trading 12,700 units of PMD stock currently worth $59,182.

What does Psychemedics do?

psychemedics (nasdaq: pmd) is the world's leading drug testing company using hair for the detection of drugs of abuse. psychemedics has been successfully operating for 30 years and thousands of corporations worldwide currently rely on psychemedics’ patented hair analysis technology for their pre-employment and employee drug screening. psychemedics'​ clients include over 10% of the fortune 500, some of the largest police departments in america, federal reserve banks, and schools. for more information, visit the psychemedics website at www.psychemedics.com.

Complete history of Richard Christoph stock trades at Psychemedics

Psychemedics executives and stock owners

Psychemedics executives and other stock owners filed with the SEC include:

• Raymond Kubacki,
  Chairman of the Board, President, Chief Executive Officer
• Raymond C. Kubacki,
  Chairman, CEO & Pres
• Charles Doucot,
  Executive Vice President
• Michael Schaffer,
  Vice President - Laboratory Operations
• Charles M. Doucot IV,
  Exec. VP
• Dr. Michael I. Schaffer Ph.D.,
  VP of Laboratory Operations
• A. Clinton Allen,
  Independent Director
• Fred Weinert,
  Independent Director
• Walter Tomenson,
  Independent Director
• Harry Connick,
  Independent Director
• Patrick J. Kinney Jr.,
  Sec.
• Sarah Ashby,
  VP & Gen. Counsel
• Andrew Limbek,
  VP of Fin. & Controller
• Annette Baumgartner,
  Founder
• Dr. Werner A. Baumgartner Ph.D.,
  Founder
• Peter Kamin,
  Director
• Neil Lerner,
  VP - Finance
• James V. Dyke,
  Vice President - Sales
• Michael Weisenhoff,
  
• Raymond J Ruddy,
  Vice President/Controller
• Jonathan D Compton,
  Vice President - Marketing
• William R Thistle,
  Sr. VP and Gen. Counsel
• Peter C Monson,
  VP, Treas., CFO & Asst. Sec.
• Jennifer Chmieleski,
  Vice President, Controller
• Richard T Christoph,
  10% owner
• William Dausey,
  Vice President of Sales
• Robyn C Davis,
  Director
• Andrew Reynolds,
  Director
• Shannon Shoemaker,
  Chief Revenue Officer
• Darius G Nevin,
  Director
• Brian Hullinger,
  President & CEO
• Daniella Mehalik,
  Vice President - Finance